[
  {
    "ts": "2026-01-07T02:10:00+00:00",
    "headline": "Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access",
    "summary": "Following Oral Wegovy Introduction, Consumer Analysis Examines Injectable vs Oral Semaglutide Pricing, Compounded Tirzepatide Access Through Direct Meds, and Three-Entity Telehealth Platform StructureHOUSTON, TX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Medical decisions about prescription weight-management treatments are appropriately made with a qualified clinician who can evaluate individual risks and eligibility.",
    "url": "https://finance.yahoo.com/news/best-peptides-weight-loss-2026-021000107.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "575dbca8-b996-3188-9676-aa0919f8349f",
      "content": {
        "id": "575dbca8-b996-3188-9676-aa0919f8349f",
        "contentType": "STORY",
        "title": "Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access",
        "description": "",
        "summary": "Following Oral Wegovy Introduction, Consumer Analysis Examines Injectable vs Oral Semaglutide Pricing, Compounded Tirzepatide Access Through Direct Meds, and Three-Entity Telehealth Platform StructureHOUSTON, TX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Medical decisions about prescription weight-management treatments are appropriately made with a qualified clinician who can evaluate individual risks and eligibility.",
        "pubDate": "2026-01-07T02:10:00Z",
        "displayTime": "2026-01-07T02:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/df21957acdd7c42436e3aaedec558622",
          "originalWidth": 160,
          "originalHeight": 37,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xS8T3RYGrDPJRFqfUJN7LQ--~B/aD0zNzt3PTE2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/df21957acdd7c42436e3aaedec558622.cf.webp",
              "width": 160,
              "height": 37,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/039gIHMOyF50T_.LvM5i0Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/df21957acdd7c42436e3aaedec558622.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/best-peptides-weight-loss-2026-021000107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-peptides-weight-loss-2026-021000107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T01:50:00+00:00",
    "headline": "Warning: This Skyrocketing Stock Has a Hidden Risk",
    "summary": "Novo Nordisk's new GLP-1 pill highlights the risk that Eli Lilly faces, as investors reward it for being at the forefront of the weight loss market.",
    "url": "https://www.fool.com/investing/2026/01/06/warning-skyrocketing-stock-hidden-risk-lly/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "65266ece-00cb-340b-8630-4a3b1a187036",
      "content": {
        "id": "65266ece-00cb-340b-8630-4a3b1a187036",
        "contentType": "STORY",
        "title": "Warning: This Skyrocketing Stock Has a Hidden Risk",
        "description": "",
        "summary": "Novo Nordisk's new GLP-1 pill highlights the risk that Eli Lilly faces, as investors reward it for being at the forefront of the weight loss market.",
        "pubDate": "2026-01-07T01:50:00Z",
        "displayTime": "2026-01-07T01:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/9e232c91e4847823108a7df0acac4130",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "People in business attire leaving the starting line on a track.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CDRGF1muIS2SuyvzghsAVg--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/9e232c91e4847823108a7df0acac4130.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5jDXQKQhPaRHYHTl3MeuJA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/9e232c91e4847823108a7df0acac4130.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/06/warning-skyrocketing-stock-hidden-risk-lly/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/warning-skyrocketing-stock-hidden-risk-015000651.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T10:50:28+00:00",
    "headline": "Trending tickers: Micron, Sandisk Corporation, Ventyx Biosciences, BP and Reckitt",
    "summary": "The latest investor updates on stocks that are trending on Wednesday.",
    "url": "https://uk.finance.yahoo.com/news/micron-sandisk-corporation-ventyx-biosciences-bp-reckitt-trending-tickers-105028144.html",
    "source": "Yahoo Finance UK",
    "provider": "yfinance",
    "raw": {
      "id": "cf806b0e-7f4e-402e-9fc6-3ae7589d9b5a",
      "content": {
        "id": "cf806b0e-7f4e-402e-9fc6-3ae7589d9b5a",
        "contentType": "STORY",
        "title": "Trending tickers: Micron, Sandisk Corporation, Ventyx Biosciences, BP and Reckitt",
        "description": "",
        "summary": "The latest investor updates on stocks that are trending on Wednesday.",
        "pubDate": "2026-01-07T10:50:28Z",
        "displayTime": "2026-01-07T10:50:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/e54a36b0-eba6-11f0-93f7-69524f11062e",
          "originalWidth": 4874,
          "originalHeight": 3077,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gC5bsfuBa4t6QvJQWAjrNQ--~B/aD0zMDc3O3c9NDg3NDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/e54a36b0-eba6-11f0-93f7-69524f11062e.cf.webp",
              "width": 4874,
              "height": 3077,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kDHMPJbFVj4Bk_Pij2j_2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/e54a36b0-eba6-11f0-93f7-69524f11062e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance UK",
          "url": "http://uk.finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/micron-sandisk-corporation-ventyx-biosciences-bp-reckitt-trending-tickers-105028144.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/micron-sandisk-corporation-ventyx-biosciences-bp-reckitt-trending-tickers-105028144.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MU"
            },
            {
              "symbol": "SNDK"
            },
            {
              "symbol": "VTYX"
            },
            {
              "symbol": "RKT.L"
            },
            {
              "symbol": "BP.L"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "WDC"
            },
            {
              "symbol": "^FTSE"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "000660.KS"
            },
            {
              "symbol": "005930.KS"
            },
            {
              "symbol": "STX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:13:34+00:00",
    "headline": "Eli Lilly Nears Deal to Buy Ventyx Biosciences for Over $1 Billion",
    "summary": "Biotech acquisition would expand Lilly's pipeline in inflammatory and metabolic diseases",
    "url": "https://finance.yahoo.com/news/eli-lilly-nears-deal-buy-121334624.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "e9d69a5d-fe20-3a75-ab6c-7ad80abb3a91",
      "content": {
        "id": "e9d69a5d-fe20-3a75-ab6c-7ad80abb3a91",
        "contentType": "STORY",
        "title": "Eli Lilly Nears Deal to Buy Ventyx Biosciences for Over $1 Billion",
        "description": "",
        "summary": "Biotech acquisition would expand Lilly's pipeline in inflammatory and metabolic diseases",
        "pubDate": "2026-01-07T12:13:34Z",
        "displayTime": "2026-01-07T12:13:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/434a82c75d97e3a5a22898838638d64c",
          "originalWidth": 6382,
          "originalHeight": 4786,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Klfzvp39.soPeoaiqKcS3w--~B/aD00Nzg2O3c9NjM4MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/434a82c75d97e3a5a22898838638d64c.cf.webp",
              "width": 6382,
              "height": 4786,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W9CEpukOrGiNcDXN4UIi7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/434a82c75d97e3a5a22898838638d64c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-nears-deal-buy-121334624.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-nears-deal-buy-121334624.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VTYX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:13:20+00:00",
    "headline": "Is Eli Lilly (LLY) Still Sensibly Priced After Its Strong Multi Year Share Price Run",
    "summary": "If you are wondering whether Eli Lilly's share price still makes sense after a long run up, or if the stock is starting to look stretched, this article walks through what the current market price could be implying about value. The stock most recently closed at US$1,064.04, with a 1.5% decline over the last 7 days, a 5.3% gain over the last 30 days, a 1.5% decline year to date, a 38.6% return over 1 year and a very large 5-year return that is well above 7x. Recent coverage of Eli Lilly has...",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-sensibly-121320690.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "88034f23-eb06-3981-bf93-95009dc4befc",
      "content": {
        "id": "88034f23-eb06-3981-bf93-95009dc4befc",
        "contentType": "STORY",
        "title": "Is Eli Lilly (LLY) Still Sensibly Priced After Its Strong Multi Year Share Price Run",
        "description": "",
        "summary": "If you are wondering whether Eli Lilly's share price still makes sense after a long run up, or if the stock is starting to look stretched, this article walks through what the current market price could be implying about value. The stock most recently closed at US$1,064.04, with a 1.5% decline over the last 7 days, a 5.3% gain over the last 30 days, a 1.5% decline year to date, a 38.6% return over 1 year and a very large 5-year return that is well above 7x. Recent coverage of Eli Lilly has...",
        "pubDate": "2026-01-07T12:13:20Z",
        "displayTime": "2026-01-07T12:13:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-sensibly-121320690.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-sensibly-121320690.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T12:00:00+00:00",
    "headline": "Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio",
    "summary": "Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced an oversubscribed $76 million Series B financing co-led by Amplitude Ventures and ICG, with participation from new investors Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust (ARE), and existing Series A investors. Joining the Mediar board from Amplitude Ventures is Bharat Srinivasa, PhD, and from ICG is Allan Marchington, PhD. Pro",
    "url": "https://finance.yahoo.com/news/mediar-therapeutics-announces-oversubscribed-76-120000921.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b94db6d7-0489-3964-a2a5-38498313685b",
      "content": {
        "id": "b94db6d7-0489-3964-a2a5-38498313685b",
        "contentType": "STORY",
        "title": "Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio",
        "description": "",
        "summary": "Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced an oversubscribed $76 million Series B financing co-led by Amplitude Ventures and ICG, with participation from new investors Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust (ARE), and existing Series A investors. Joining the Mediar board from Amplitude Ventures is Bharat Srinivasa, PhD, and from ICG is Allan Marchington, PhD. Pro",
        "pubDate": "2026-01-07T12:00:00Z",
        "displayTime": "2026-01-07T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/6024aabeb42cccbade6e46ac9a1d4ca3",
          "originalWidth": 400,
          "originalHeight": 150,
          "caption": "Mediar Therapeutics logo (PRNewsfoto/Mediar Therapeutics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J.Y1EFIP6VAquwc3xHxu8w--~B/aD0xNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6024aabeb42cccbade6e46ac9a1d4ca3.cf.webp",
              "width": 400,
              "height": 150,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gwbhFt2ZTLm6QzvY77mBKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6024aabeb42cccbade6e46ac9a1d4ca3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mediar-therapeutics-announces-oversubscribed-76-120000921.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mediar-therapeutics-announces-oversubscribed-76-120000921.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T11:34:47+00:00",
    "headline": "Stocks to Watch Wednesday: Strategy, Applied Digital, Ventyx, Mobileye",
    "summary": "↗️ Strategy (MSTR): Index provider MSCI said it won't exclude crypto treasury companies from its indexes. Shares of bitcoin accumulator Strategy climbed 4% in premarket trading. ↘️ Newmont (NEM), Freeport-McMoRan (FCX), Antofagasta (UK: ANTO): Global mining stocks came under pressure as a rally in precious and industrial metals stalled.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-07-2026/card/stocks-to-watch-wednesday-strategy-newmont-caterpillar-zsZqDS9uY17bxWVWaoiH?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "88cdf999-420b-3e40-85e4-c591190aabda",
      "content": {
        "id": "88cdf999-420b-3e40-85e4-c591190aabda",
        "contentType": "STORY",
        "title": "Stocks to Watch Wednesday: Strategy, Applied Digital, Ventyx, Mobileye",
        "description": "",
        "summary": "↗️ Strategy (MSTR): Index provider MSCI said it won't exclude crypto treasury companies from its indexes. Shares of bitcoin accumulator Strategy climbed 4% in premarket trading. ↘️ Newmont (NEM), Freeport-McMoRan (FCX), Antofagasta (UK: ANTO): Global mining stocks came under pressure as a rally in precious and industrial metals stalled.",
        "pubDate": "2026-01-07T11:34:47Z",
        "displayTime": "2026-01-07T11:34:47Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/88cdf999-420b-3e40-85e4-c591190aabda/stocks-to-watch-wednesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/88cdc7803b870291daefe4b4f1eaeed3",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LBNZqD1vSZ3knEFLkyzdJw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/88cdc7803b870291daefe4b4f1eaeed3.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ww64e.65AiKwuQtcYwB0w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/88cdc7803b870291daefe4b4f1eaeed3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-07-2026/card/stocks-to-watch-wednesday-strategy-newmont-caterpillar-zsZqDS9uY17bxWVWaoiH?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MBLY"
            },
            {
              "symbol": "ANFGF"
            },
            {
              "symbol": "005380.KS"
            },
            {
              "symbol": "005385.KS"
            },
            {
              "symbol": "005387.KS"
            },
            {
              "symbol": "005389.KS"
            },
            {
              "symbol": "CVX"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "VTYX"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "APLD"
            },
            {
              "symbol": "NEM"
            },
            {
              "symbol": "FCX"
            },
            {
              "symbol": "QTCI"
            },
            {
              "symbol": "LKOH.ME"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]